WO2021240315A1 - Probiotic bacillus sanitiser - Google Patents

Probiotic bacillus sanitiser Download PDF

Info

Publication number
WO2021240315A1
WO2021240315A1 PCT/IB2021/054415 IB2021054415W WO2021240315A1 WO 2021240315 A1 WO2021240315 A1 WO 2021240315A1 IB 2021054415 W IB2021054415 W IB 2021054415W WO 2021240315 A1 WO2021240315 A1 WO 2021240315A1
Authority
WO
WIPO (PCT)
Prior art keywords
sanitiser
bacillus
probiotic
probiotic bacillus
sodium
Prior art date
Application number
PCT/IB2021/054415
Other languages
French (fr)
Inventor
Dylan John SETTER
Quinten Colin DICKERSON
Original Assignee
Setter Dylan John
Dickerson Quinten Colin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Setter Dylan John, Dickerson Quinten Colin filed Critical Setter Dylan John
Publication of WO2021240315A1 publication Critical patent/WO2021240315A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00Disinfectants; Antimicrobial compounds or mixtures thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20Bacteria; Substances produced thereby or obtained therefrom
    • A01N63/22Bacillus
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P3/00Fungicides

Definitions

  • the invention herein described refers to a probiotic Bacillus surface sanitiser comprising a sanitiser, a probiotic Bacillus and a surfactant, but excluding any stabiliser, as well as a process for manufacturing the probiotic Bacillus surface sanitiser.
  • the invention further refers to a method of killing or inhibition of the growth of pathogenic or undesirable microorganisms on a surface by application of the probiotic Bacillus surface sanitiser of the invention.
  • Sanitising agents, disinfectants or biocides including those for treating surfaces are typically comprised of chemicals or enzymes that are designed to kill or limit the growth of microorganisms including bacteria, fungi, viruses, algae and protozoa in order to prevent the harmful consequences of the presence and activity of such microorganisms.
  • Such products may be used in medical settings as well as in industrial products or processes, in public spaces, or even in the home, but it is well known that conventional sanitisers, disinfectants and biocides often pose significant risk to both the natural environment and human and animal health by killing the beneficial bacteria as well as the pathogenic or undesirable bacteria, leaving the surface being treated unprotected from further accelerated growth of pathogenic or undesirable bacteria due to the beneficial bacteria also no longer being present.
  • Manufacture and use of chemical sanitisers, disinfectants and biocides is strictly regulated due to the toxic and corrosive content, particularly in the food, medical, pharmaceutical, agriculture, cosmetic and water industries.
  • Sanitisers or disinfectants to inactivate or inhibit the growth of microorganisms are dependent on the contact time and the concentrations applied. However, due to increased resistance of microorganisms to conventionally used sanitisers and disinfectants, the contact time and concentration have needed to be increased over time to remain effective. Furthermore, certain species of bacteria can form spores or a biofilm to survive the effects of a sanitiser or disinfectant.
  • a probiotic Bacillus sanitiser for killing or inhibiting the growth of microorganisms on a surface comprising or consisting of:
  • water optionally water, and/or additives including one or more colourants, fragrances, effervescent compounds, fillers such as soda ash (sodium bicarbonate) or sodium chloride, degreasing agents, and cleaning agents if desired, wherein no stabilising chemicals are present.
  • additives including one or more colourants, fragrances, effervescent compounds, fillers such as soda ash (sodium bicarbonate) or sodium chloride, degreasing agents, and cleaning agents if desired, wherein no stabilising chemicals are present.
  • the probiotic Bacillus sanitiser may further comprise one or more colourants, fragrances or effervescent compounds such as soda ash (sodium bicarbonate) if desired.
  • the Bacillus may be any one or more isolated GRAS (generally classified as safe) Bacillus species known to those skilled in the art, for example, B. subtilis, B. pumilus and B. megaterium, B. licheniformis, B. coagulans, B. mojavensis, or B. amyloliquefaciens as well as any other Bacillus species that may be discovered in future or are not currently utilized.
  • GRAS generally classified as safe Bacillus species known to those skilled in the art, for example, B. subtilis, B. pumilus and B. megaterium, B. licheniformis, B. coagulans, B. mojavensis, or B. amyloliquefaciens as well as any other Bacillus species that may be discovered in future or are not currently utilized.
  • the sanitising agent may be any one or more chemical sanitiser(s) known to those skilled in the art, for example chlorine, sodium dichloroisocyanurate (SDIC), chlorine dioxide, hypochlorous acid, hydrogen peroxide, sodium hypochorite, quaternary ammonium, alcohol such as ethanol or isopropyl alcohol or any derivative of the above.
  • the chemical sanitiser is SDIC or quaternary ammonium.
  • the sanitiser may be a natural sanitiser known to those skilled in the art, such as comprising one or more essential oils or compounds including enzymes and/or flavonoids from antiseptic plants, such as eucalyptus, neem, mint, rosemary, tea tree, witch-hazel, citrus peel, lactic acid and the like.
  • the surfactant may be any one or more cationic and/or one or more non-ionic surfactant(s) known to those skilled in the art.
  • Cationic surfactants are those where the polar group carries a positive charge, for example dimethyl distearyl ammonium chloride or sodium dodecylbenzene sulfonate.
  • Non-ionic surfactants have a polar group that cannot be ionized in an aqueous solution, a fatty acid chain forming a hydrophobic component and a hydrophilic component containing non ionizable atoms of oxygen, nitrogen or sulphur.
  • Examples include derivatives of polyoxyethylene (POE) or polyoxypropylene (POP), sugar esters and alkanolamides.
  • the pH of the probiotic sanitiser may be between about 4.5 to about 9.5, or from about 5 to 9, or about 3.5 to 10.5, or about 8 to 9, or about 7 to 10, or about 9.5 to 10.5.
  • a buffering agent known to those skilled in the art may be added to obtain the desired pH.
  • the probiotic Bacillus sanitiser may be in a liquid or a dry (solid) form.
  • the liquid form may be formulated as a stock solution for further dilution by a user or distributor, or may be formulated ready to use.
  • the solid form may be any solid formulation including a granular or powder formulation which can be mixed with water to the desired liquid concentration by a user or distributor.
  • the solid form may further comprise a filler including soda ash (sodium carbonate) or sodium chloride or other known fillers.
  • a filler is a particulate material that is added to the probiotic Bacillus sanitiser to bulk it up and make the final product cheaper, but may also have beneficial properties.
  • the probiotic sanitiser may further comprise degreasing components including soda ash (sodium carbonate), sodium tripolyphosphate, tetrapotassium pyrophosphate, sodium metasilicate anhydrous and sodium dodecylbenzene sulfonate.
  • degreasing components including soda ash (sodium carbonate), sodium tripolyphosphate, tetrapotassium pyrophosphate, sodium metasilicate anhydrous and sodium dodecylbenzene sulfonate.
  • the probiotic Bacillus sanitiser is formulated as a liquid product and comprises per 1 ,000 L:
  • Bacillus sp. at between about 6,00E+05 to about at least 0,0001% - 30%
  • the probiotic Bacillus sanitiser is formulated as a dry product and comprises per 1 ,000 g:
  • the probiotic sanitiser is formulated as a chemical degreasing probiotic Bacillus sanitiser and comprises per 1,000 g:
  • Bacillus sp. at between about 6,00E+05 to about at least 0,0001% - 30%
  • a simplified process for manufacturing a probiotic Bacillus sanitiser of the invention comprising or consisting of a step of blending:
  • the Bacillus may be any one or more isolated GRAS (generally classified as safe) Bacillus species known to those skilled in the art, for example, B. subtilis, B. pumilus and B. megaterium, B. licheniformis, B. coagulans, B. mojavensis, or B. amyloliquefaciens as well as any other Bacillus species that may be discovered in future or are not currently utilized.
  • GRAS generally classified as safe Bacillus species known to those skilled in the art, for example, B. subtilis, B. pumilus and B. megaterium, B. licheniformis, B. coagulans, B. mojavensis, or B. amyloliquefaciens as well as any other Bacillus species that may be discovered in future or are not currently utilized.
  • the sanitising agent may be any one or more chemical sanitiser(s) known to those skilled in the art, for example chlorine, sodium dichloroisocyanurate (SDIC), chlorine dioxide, hypochlorous acid, hydrogen peroxide, sodium hypochorite, quaternary ammonium, alcohol such as ethanol or isopropyl alcohol or any derivative of the above.
  • the chemical sanitiser is SDIC or quaternary ammonium.
  • the sanitising agent may be a natural sanitiser known to those skilled in the art, such as comprising one or more essential oils or compounds including enzymes and/or flavonoids from antiseptic plants, such as eucalyptus, neem, mint, rosemary, tea tree, witch-hazel, citrus peel or lactic acid and the like.
  • a natural sanitiser known to those skilled in the art, such as comprising one or more essential oils or compounds including enzymes and/or flavonoids from antiseptic plants, such as eucalyptus, neem, mint, rosemary, tea tree, witch-hazel, citrus peel or lactic acid and the like.
  • the surfactant may be any one or more cationic or non-ionic surfactant known to those skilled in the art.
  • Cationic surfactants are those where the polar group carries a positive charge, for example dimethyl distearyl ammonium chloride or sodium dodecylbenzene sulfonate.
  • Non-ionic surfactants have a polar group that cannot be ionized in an aqueous solution, a fatty acid chain forming a hydrophobic component and a hydrophilic component containing non ionizable atoms of oxygen, nitrogen or sulphur. Examples include derivatives of polyoxyethylene (POE) or polyoxypropylene (POP), sugar esters and alkanolamides.
  • POE polyoxyethylene
  • POP polyoxypropylene
  • the pH of the probiotic sanitiser may between about 4.5 to about 9.5, or from about 5 to 9, or about 3.5 to 10.5 or about 8 to 9. In one embodiment of the invention, the pH is between about 7 to 10. In an alternative embodiment of the invention, the pH is between about 9.5 and 10.5.
  • a pH adjusting agent known to those skilled in the art may be added to obtain the desired pH, including but not limited to potassium hydroxide, sodium hydroxide, glycolic acid.
  • the process may be for manufacturing of a liquid probiotic Bacillus sanitiser formulation and may comprise providing water to a mixing tank followed by addition of each of the active components and optionally one or more additives, and mixing until blended before packaging.
  • the process may be for manufacturing of a granular or powder dry (or solid) probiotic Bacillus sanitiser formulation and may comprise providing each of the active components in dry form and optionally one or more additives in dry form to a mixer, and mixing until blended.
  • the process may further comprise forming the solid sanitiser into a tablet by stamping the solid formulation into a mould before packaging.
  • microorganism(s) may be one or more bacteria, one or more virus(es), one or more fungus(i), one or more protozoa or one or more algae.
  • the microorganism may be one or more bacteria or one or more fungi.
  • the method may comprise dilution of a liquid formulation of the probiotic sanitiser of the invention to a desired concentration prior to use.
  • the dilution factor may be 1 :10 parts probiotic Bacillus sanitisenwater.
  • Application may comprise spraying the probiotic sanitiser of the invention at the desired concentration onto the surface and wiping the surface followed by allowing the surface to dry naturally.
  • application may comprise providing a bucket containing the probiotic Bacillus sanitiser of the invention at the desired concentration, and application of the probiotic Bacillus sanitiser by means of a mop or cloth dipped into the bucket and then used to wipe or mop the surface, followed by natural drying of the surface.
  • the method may comprise dissolving the dry probiotic Bacillus sanitiser of the invention in water to obtain a liquid formulation.
  • the liquid formulation may be further diluted to a desired concentration prior to use or may be mixed at the desired concentration without requiring further dilution.
  • 50g of dry probiotic Bacillus sanitiser may be mixed with 10L of water, followed by stirring until completely dissolved, and use within 3 hours of mixing, or if stored in an air tight container, use within 12 hours.
  • the current invention relates to a probiotic Bacillus surface sanitiser for killing or inhibiting the growth of microorganisms on a surface comprising at least one species of Bacillus, at least one sanitiser, and at least one surfactant, wherein no stabilising chemicals are present.
  • the invention further provides a process for manufacturing the probiotic Bacillus sanitiser.
  • the invention further refers to a method of killing or inhibition of the growth of pathogenic or undesirable microorganisms on a surface by application of the probiotic Bacillus sanitiser of the invention.
  • sanitiser sanitising agent
  • disinfectant a compound or composition that is active to inhibit the growth of a microorganisms or to kill a microorganism.
  • stabilisers that have been used in the past, but are not required for use in the formulation of the invention include: polyethylene glycol, or another humectant, such as glycerine, glycerol, an ethylene oxide polymer, 1 ,2-dihydroxypropane, 1,2- propanediol, methyl glycol, or trimethyl glycol, or sodium benzoate, nitrate, nitrite, sodium nitrate, benzoic acid, suphure dioxide, benzalkonium chloride, benzyle alcohol, paraben, tartaric, acetic or citric acid, or isothiazolinone.
  • polyethylene glycol or another humectant, such as glycerine, glycerol, an ethylene oxide polymer, 1 ,2-dihydroxypropane, 1,2- propanediol, methyl glycol, or trimethyl glycol, or sodium benzoate, nitrate, nitrite, sodium nitrate, benzoic acid,
  • Disinfectants or sanitisers are used in medical settings as well as in industrial products or processes but may also be used in the home, office or in public places.
  • the chemical disinfectants being used need to be replaced with new chemical disinfectants as resistance developes, in order for the product to be effective.
  • many of these compounds and compositions are known to have toxic and/or corrosive content and are detrimental to human and animal health and to the natural environment, particularly at the high concentrations and frequency of use required for long-lasting effectiveness.
  • certain species of bacteria can form spores or a biofilm to survive the effects of a conventional chemical or natural sanitiser.
  • the sanitiser component of the product provides initial disinfection and sanitation by killing or inhibition of pathogenic and undesirable microorganisms upon application to the surface. Thereafter, the probiotic Bacillus bacteria continue to function, maintaining a healthy bacterial environment that limits the ingress of pathogenic or undesirable microorganisms through competition with undesirable/pathogenic bacteria by consuming the available food source.
  • the probiotic sanitiser of the invention can be effectively used to disinfect or sanitise any surface, including those in industrial, medical, pharmaceutical, agricultural, business, public or domestic spaces and including but not limited to: work surfaces, floors, walls, railings, handles, operating buttons, coveyers, processing and packaging equipment, and the like.
  • Bacillus sp. (about 6.00E+06 to about 1 ,00E+9 0,001 % - 30%
  • one or more additives including one or more colourants or fragrances may be added.
  • the diluted pH value is between 7 and 10.
  • Step 1 Add water into a mixing tank or vessel.
  • Step 2 Add each of the chemicals and Bacillus sp. and mix the product for 2 mins or until completely mixed.
  • Step 3 Decant into packaging for distribution, sale and use.
  • Dilute probiotic Bacillus sanitiser product by adding to a bucket of water or spray bottle at 1 :10 parts water: probiotic Bacillus sanitiser and apply to the relevant surface with a mop, cloth or spray. Wipe down the surface or allow to dry naturally. It is also possible to dilute the probiotic Bacillus sanitiser in an alternative concentration as desired or specific to a particular application.
  • EXAMPLE 2 Dilute probiotic Bacillus sanitiser product by adding to a bucket of water or spray bottle at 1 :10 parts water: probiotic Bacillus sanitiser and apply to the relevant surface with a mop, cloth or spray. Wipe down the surface or allow to dry naturally. It is also possible to dilute the probiotic Bacillus sanitiser in an alternative concentration as desired or specific to a particular application.
  • EXAMPLE 2 EXAMPLE 2:
  • additives may be included such as one or more colourants, or fragrances.
  • the diluted pH value is between 7 and 10.
  • Step 1 Add each of the dry chemicals and Bacillus sp. to a mechanical mixer in the quantities provided above.
  • Step 2 Turn on mixer and mix for 10 minutes or until thourghly mixed.
  • Step 3 Decant the finished dry probiotic Bacillus sanitiser into packaging for distribution, sale and use.
  • the diluted pH value is between 9.5 and 10.5.
  • Step 1 Add the each of the dry chemicals and Bacillus sp. to a mechanical mixer in the quantities provided above.
  • Step 2 Turn on mixer and mix for 10 minutes or until thoroughly mixed.
  • Step 3 Decant the finished dry degreasing probiotic Bacillus sanitiser into packaging for distribution, sale and use.
  • Bacterial pathgens Efficacy of reconstituted powder formulation in water of probiotic sanitiser with Bacillus sp. (between about 6,00E+06 to about 1 ,00E+9 CFU), sodium dichloro iso cynurate (SDIC) >50PPM chemical sanitiser, and 10% surfactant plus soda ash or sodium chloride as a filler was tested against four pathogenic bacterial species by an accredited laboratory.
  • the pass requirements in terms of the accredited test is that the product must demonstrate at least a 5 decimal log reduction in bacteria when diluted with hard water or undiluted.
  • the probiotic sanitiser was tested against four bacterial species: Enterococcus hirae ATCC 10541 , Escherichia coli ATCC 10536, Pseudomonas aeruginosa ATCC 15442 and Staphylococcus aureus ATCC 6538 for a contact time of 5 minutes at 20 °C. An amount of 0.3 g/L bovine serum albumin as added as the interfering substance. Thereafter samples were tested at 37 °C for bacterial growth.
  • N is between 1.5x10 8 and 5.0x10 8 (8.17 ⁇ log N ⁇ 8.70)
  • N v o is between 30 and 160 (3.0x10 1 and 1.6x10 2 )
  • A, B, C are equal to or greater than 0.5xN v o
  • probiotic sanitiser test product tested at either 60g / 10L or 90g / 10L complied with the pass criteria of SANS test 51276 (EN1276) standard, which requires at least a 99.999% kill (5 log reduction) in bacteria.
  • the probiotic sanitiser was tested against two fungal strains: Candida albicans ATCC 10231 and Aspergillus brasiliensis ATCC 16404 for a contact time of 15 minutes at 20 °C. An amount of 0.3 g/L bovine serum albumin as added as the interfering substance. Thereafter samples were tested at 30 °C for bacterial growth.
  • N is between 1 .5x10 7 and 5.0x10 7 (7.17 ⁇ log N ⁇ 7.70)
  • A, B, C are equal to or greater than 0.5xN v o
  • probiotic sanitiser test product tested at either 60g / 10L or 90g / 10L complied with the pass criteria of SANS test 53624:2011 (EN13624) standard, which requires at least a 99.99% kill (4 log reduction) in fungus.
  • the probiotic sanitiser was tested against three bacterial species: Enterococcus hirae ATCC 10541, Pseudomonas aeruginosa ATCC 15442 and Staphylococcus aureus ATCC 6538 for a contact time of 5 minutes at 20 °C. An amount of 0.3 g/L bovine serum albumin as added as the interfering substance. Thereafter samples were tested at 37 °C for bacterial growth.
  • N is between 1.5x10 8 and 5.0x10 8 (8.17 ⁇ log N ⁇ 8.70)
  • probiotic sanitiser test product tested at a dilution of 10% v/v or undiluted complied with the pass criteria of SANS test 53727:2011 (EN13727:2003) standard, which requires at least a 99.999% kill (5 log reduction) in bacteria.
  • the probiotic sanitiser was tested against two fungal strains: Candida albicans ATCC 10231 and Aspergillus brasiliensis ATCC 16404 for a contact time of 15 minutes at 20 °C. An amount of 0.3 g/L bovine serum albumin as added as the interfering substance. Thereafter samples were tested at 30 °C for bacterial growth.
  • N is between 1.5x10 7 and 5.0x10 7 (7.17 ⁇ log N ⁇ 7.70)
  • A, B, C are equal to or greater than 0.5xN v o
  • probiotic sanitiser test product tested at tested at a dilution of 10% v/v or undiluted complied with the pass criteria of standard SANS test 53624:2011 (EN13624) standard, which requires at least a 99.99% kill (4 log reduction) in fungus.

Abstract

The invention herein described refers to a probiotic Bacillus surface sanitiser comprising a sanitising agent, a probiotic Bacillus sp. and a surfactant, but excluding any stabiliser, as well as a process for manufacturing the probiotic Bacillus surface sanitiser. The invention further refers to a method of killing or inhibition of the growth of pathogenic or undesirable microorganisms on a surface by application of the probiotic Bacillus surface sanitiser of the invention.

Description

PROBIOTIC BACILLUS SANITISER
FIELD OF THE INVENTION
The invention herein described refers to a probiotic Bacillus surface sanitiser comprising a sanitiser, a probiotic Bacillus and a surfactant, but excluding any stabiliser, as well as a process for manufacturing the probiotic Bacillus surface sanitiser. The invention further refers to a method of killing or inhibition of the growth of pathogenic or undesirable microorganisms on a surface by application of the probiotic Bacillus surface sanitiser of the invention.
BACKGROUND OF THE INVENTION
Sanitising agents, disinfectants or biocides, including those for treating surfaces are typically comprised of chemicals or enzymes that are designed to kill or limit the growth of microorganisms including bacteria, fungi, viruses, algae and protozoa in order to prevent the harmful consequences of the presence and activity of such microorganisms. Such products may be used in medical settings as well as in industrial products or processes, in public spaces, or even in the home, but it is well known that conventional sanitisers, disinfectants and biocides often pose significant risk to both the natural environment and human and animal health by killing the beneficial bacteria as well as the pathogenic or undesirable bacteria, leaving the surface being treated unprotected from further accelerated growth of pathogenic or undesirable bacteria due to the beneficial bacteria also no longer being present. Manufacture and use of chemical sanitisers, disinfectants and biocides is strictly regulated due to the toxic and corrosive content, particularly in the food, medical, pharmaceutical, agriculture, cosmetic and water industries.
Sanitisers or disinfectants to inactivate or inhibit the growth of microorganisms are dependent on the contact time and the concentrations applied. However, due to increased resistance of microorganisms to conventionally used sanitisers and disinfectants, the contact time and concentration have needed to be increased over time to remain effective. Furthermore, certain species of bacteria can form spores or a biofilm to survive the effects of a sanitiser or disinfectant.
It would be useful to be able to provide a sanitising product with a natural component that is effective over an extended period but with either a reduced concentration of sanitiser/disinfectant or a reduction in the number of times that the product needs to be applied in order to maintain effectiveness, or both. Such a product could find application in many diverse settings, from the home to businesses, for public spaces including public transport, buildings and places, to medical, agricultural and industrial settings.
It would further be useful if such a sanitiser could reduce the unwanted microorganism content on surfaces without having a detrimental effect on the environment by replacing the unwanted pathogenic or undesirable microorganisms with beneficial and natural bacteria.
Furthermore it would be useful if such a product was able to act without causing damage to the surface on which it is used, such as corrosion, which is caused by frequent application of high concentrations of chemical sanitisers used at present.
In addition, it would be beneficial if the sanitiser was able to be simply manufactured without requiring the addition of stabilising chemicals, thereby to reduce the cost of production and simplifying the manufacturing process. SUMMARY OF THE INVENTION
According to a first embodiment of the invention, there is provided a probiotic Bacillus sanitiser for killing or inhibiting the growth of microorganisms on a surface comprising or consisting of:
(i) as active ingredients, at least one species of Bacillus, at least one sanitising agent, and at least one surfactant; and
(ii) optionally water, and/or additives including one or more colourants, fragrances, effervescent compounds, fillers such as soda ash (sodium bicarbonate) or sodium chloride, degreasing agents, and cleaning agents if desired, wherein no stabilising chemicals are present.
The probiotic Bacillus sanitiser may further comprise one or more colourants, fragrances or effervescent compounds such as soda ash (sodium bicarbonate) if desired.
The Bacillus may be any one or more isolated GRAS (generally classified as safe) Bacillus species known to those skilled in the art, for example, B. subtilis, B. pumilus and B. megaterium, B. licheniformis, B. coagulans, B. mojavensis, or B. amyloliquefaciens as well as any other Bacillus species that may be discovered in future or are not currently utilized.
The sanitising agent may be any one or more chemical sanitiser(s) known to those skilled in the art, for example chlorine, sodium dichloroisocyanurate (SDIC), chlorine dioxide, hypochlorous acid, hydrogen peroxide, sodium hypochorite, quaternary ammonium, alcohol such as ethanol or isopropyl alcohol or any derivative of the above. In a preferred embodiment of the invention, the chemical sanitiser is SDIC or quaternary ammonium.
Alternatively, the sanitiser may be a natural sanitiser known to those skilled in the art, such as comprising one or more essential oils or compounds including enzymes and/or flavonoids from antiseptic plants, such as eucalyptus, neem, mint, rosemary, tea tree, witch-hazel, citrus peel, lactic acid and the like. The surfactant may be any one or more cationic and/or one or more non-ionic surfactant(s) known to those skilled in the art. Cationic surfactants are those where the polar group carries a positive charge, for example dimethyl distearyl ammonium chloride or sodium dodecylbenzene sulfonate. Non-ionic surfactants have a polar group that cannot be ionized in an aqueous solution, a fatty acid chain forming a hydrophobic component and a hydrophilic component containing non ionizable atoms of oxygen, nitrogen or sulphur. Examples include derivatives of polyoxyethylene (POE) or polyoxypropylene (POP), sugar esters and alkanolamides.
The pH of the probiotic sanitiser may be between about 4.5 to about 9.5, or from about 5 to 9, or about 3.5 to 10.5, or about 8 to 9, or about 7 to 10, or about 9.5 to 10.5. A buffering agent known to those skilled in the art may be added to obtain the desired pH.
The probiotic Bacillus sanitiser may be in a liquid or a dry (solid) form. The liquid form may be formulated as a stock solution for further dilution by a user or distributor, or may be formulated ready to use. The solid form may be any solid formulation including a granular or powder formulation which can be mixed with water to the desired liquid concentration by a user or distributor. In particular, the solid form may further comprise a filler including soda ash (sodium carbonate) or sodium chloride or other known fillers. A filler is a particulate material that is added to the probiotic Bacillus sanitiser to bulk it up and make the final product cheaper, but may also have beneficial properties.
The probiotic sanitiser may further comprise degreasing components including soda ash (sodium carbonate), sodium tripolyphosphate, tetrapotassium pyrophosphate, sodium metasilicate anhydrous and sodium dodecylbenzene sulfonate.
In one possible embodiment of the invention, the probiotic Bacillus sanitiser is formulated as a liquid product and comprises per 1 ,000 L:
Bacillus sp. at between about 6,00E+05 to about at least 0,0001% - 30%
1 ,00E+11 colony forming units (CFU) depending on the CFU of the Bacillis sp. used sanitising agent
Figure imgf000005_0001
10ppm - 1500ppm cationic and/or non-ionic surfactants 5% - 15% water 40% - 80% In an alternative possible embodiment of the invention, the probiotic Bacillus sanitiser is formulated as a dry product and comprises per 1 ,000 g:
Figure imgf000006_0002
In a further alternative possible embodiment of the invention, the probiotic sanitiser is formulated as a chemical degreasing probiotic Bacillus sanitiser and comprises per 1,000 g:
Bacillus sp. at between about 6,00E+05 to about at least 0,0001% - 30%
1 ,00E+11 CFU depending on the CFU of
Figure imgf000006_0001
According to a further aspect of the invention, there is provided a simplified process for manufacturing a probiotic Bacillus sanitiser of the invention, comprising or consisting of a step of blending:
(i) as active ingredients, at least one species of Bacillus, at least one sanitising agent, and at least one surfactant; and
(ii) optionally water and/or additives including one or more colourants, fragrances, effervescent compounds, fillers such as soda ash (sodium bicarbonate) or sodium chloride, degreasing agents, and cleaning agents if desired, where no stabiliser is added. The Bacillus may be any one or more isolated GRAS (generally classified as safe) Bacillus species known to those skilled in the art, for example, B. subtilis, B. pumilus and B. megaterium, B. licheniformis, B. coagulans, B. mojavensis, or B. amyloliquefaciens as well as any other Bacillus species that may be discovered in future or are not currently utilized.
The sanitising agent may be any one or more chemical sanitiser(s) known to those skilled in the art, for example chlorine, sodium dichloroisocyanurate (SDIC), chlorine dioxide, hypochlorous acid, hydrogen peroxide, sodium hypochorite, quaternary ammonium, alcohol such as ethanol or isopropyl alcohol or any derivative of the above. In a preferred embodiment of the invention, the chemical sanitiser is SDIC or quaternary ammonium.
Alternatively, the sanitising agent may be a natural sanitiser known to those skilled in the art, such as comprising one or more essential oils or compounds including enzymes and/or flavonoids from antiseptic plants, such as eucalyptus, neem, mint, rosemary, tea tree, witch-hazel, citrus peel or lactic acid and the like.
The surfactant may be any one or more cationic or non-ionic surfactant known to those skilled in the art. Cationic surfactants are those where the polar group carries a positive charge, for example dimethyl distearyl ammonium chloride or sodium dodecylbenzene sulfonate. Non-ionic surfactants have a polar group that cannot be ionized in an aqueous solution, a fatty acid chain forming a hydrophobic component and a hydrophilic component containing non ionizable atoms of oxygen, nitrogen or sulphur. Examples include derivatives of polyoxyethylene (POE) or polyoxypropylene (POP), sugar esters and alkanolamides.
The pH of the probiotic sanitiser may between about 4.5 to about 9.5, or from about 5 to 9, or about 3.5 to 10.5 or about 8 to 9. In one embodiment of the invention, the pH is between about 7 to 10. In an alternative embodiment of the invention, the pH is between about 9.5 and 10.5. A pH adjusting agent known to those skilled in the art may be added to obtain the desired pH, including but not limited to potassium hydroxide, sodium hydroxide, glycolic acid. The process may be for manufacturing of a liquid probiotic Bacillus sanitiser formulation and may comprise providing water to a mixing tank followed by addition of each of the active components and optionally one or more additives, and mixing until blended before packaging.
The process may be for manufacturing of a granular or powder dry (or solid) probiotic Bacillus sanitiser formulation and may comprise providing each of the active components in dry form and optionally one or more additives in dry form to a mixer, and mixing until blended. The process may further comprise forming the solid sanitiser into a tablet by stamping the solid formulation into a mould before packaging.
According to a further aspect of the invention there is provided a method of killing or inhibition of the growth of one or more pathogenic or undesirable microorganisms on a surface by application of the probiotic Bacillus sanitiser of the invention. The microorganism(s) may be one or more bacteria, one or more virus(es), one or more fungus(i), one or more protozoa or one or more algae. In particular the microorganism may be one or more bacteria or one or more fungi.
The method may comprise dilution of a liquid formulation of the probiotic sanitiser of the invention to a desired concentration prior to use. For example, the dilution factor may be 1 :10 parts probiotic Bacillus sanitisenwater.
Application may comprise spraying the probiotic sanitiser of the invention at the desired concentration onto the surface and wiping the surface followed by allowing the surface to dry naturally. Alternatively, application may comprise providing a bucket containing the probiotic Bacillus sanitiser of the invention at the desired concentration, and application of the probiotic Bacillus sanitiser by means of a mop or cloth dipped into the bucket and then used to wipe or mop the surface, followed by natural drying of the surface.
In an alternative embodiment of the invention, the method may comprise dissolving the dry probiotic Bacillus sanitiser of the invention in water to obtain a liquid formulation. The liquid formulation may be further diluted to a desired concentration prior to use or may be mixed at the desired concentration without requiring further dilution. For example, 50g of dry probiotic Bacillus sanitiser may be mixed with 10L of water, followed by stirring until completely dissolved, and use within 3 hours of mixing, or if stored in an air tight container, use within 12 hours.
DETAILED DESCRIPTION OF THE INVENTION
The current invention relates to a probiotic Bacillus surface sanitiser for killing or inhibiting the growth of microorganisms on a surface comprising at least one species of Bacillus, at least one sanitiser, and at least one surfactant, wherein no stabilising chemicals are present. The invention further provides a process for manufacturing the probiotic Bacillus sanitiser. The invention further refers to a method of killing or inhibition of the growth of pathogenic or undesirable microorganisms on a surface by application of the probiotic Bacillus sanitiser of the invention.
Throughout this specification the terms “sanitiser”, “sanitising agent”, “disinfectant” and “biocide” are used interchangeably and mean a compound or composition that is active to inhibit the growth of a microorganisms or to kill a microorganism.
Currently available surface disinfectants or sanitisers are commonly formulated either as chemical or as natural biocides or sanitisers. The use of probiotic bacteria in combination with a disinfectant or sanitiser is rare, and when combined, requires the use of stabilisers to ensure that the product remains stable prior to use. Some examples of stabilisers that have been used in the past, but are not required for use in the formulation of the invention include: polyethylene glycol, or another humectant, such as glycerine, glycerol, an ethylene oxide polymer, 1 ,2-dihydroxypropane, 1,2- propanediol, methyl glycol, or trimethyl glycol, or sodium benzoate, nitrate, nitrite, sodium nitrate, benzoic acid, suphure dioxide, benzalkonium chloride, benzyle alcohol, paraben, tartaric, acetic or citric acid, or isothiazolinone. The required addition of such compounds adds to the cost and complexity of the product and the manufacturing process.
Disinfectants or sanitisers are used in medical settings as well as in industrial products or processes but may also be used in the home, office or in public places. The use of chemical or natural sanitisers alone, due to the increasing resistance of microorganisms including bacteria, viruses and fungal pathogens, is required to be by more frequent application and in higher concentrations to remain effective. Alternatively the chemical disinfectants being used need to be replaced with new chemical disinfectants as resistance developes, in order for the product to be effective. However, many of these compounds and compositions are known to have toxic and/or corrosive content and are detrimental to human and animal health and to the natural environment, particularly at the high concentrations and frequency of use required for long-lasting effectiveness. Furthermore, certain species of bacteria can form spores or a biofilm to survive the effects of a conventional chemical or natural sanitiser.
The combination of an isolated probiotic Bacillus species together with a sanitiser has been found by the applicant to provide an effective solution for cleaning, degreasing and disinfecting surfaces with an advantage over the commonly available sanitisers on the market, in that less frequent applications of chemical sanitiser is required for effective use. The applicant has also surprisingly shown that the formulation of their product does not require the addition of a stabiliser, which has previously been required to be included in similar products, thereby saving on the cost and complexity of formulation and is still effective for use.
The sanitiser component of the product provides initial disinfection and sanitation by killing or inhibition of pathogenic and undesirable microorganisms upon application to the surface. Thereafter, the probiotic Bacillus bacteria continue to function, maintaining a healthy bacterial environment that limits the ingress of pathogenic or undesirable microorganisms through competition with undesirable/pathogenic bacteria by consuming the available food source.
The probiotic sanitiser of the invention can be effectively used to disinfect or sanitise any surface, including those in industrial, medical, pharmaceutical, agricultural, business, public or domestic spaces and including but not limited to: work surfaces, floors, walls, railings, handles, operating buttons, coveyers, processing and packaging equipment, and the like.
The invention is described by way of the following illustrated embodiments which are not to be construed as limiting in any way the scope of the invention.
EXAMPLE 1 :
Liquid probiotic sanitiser
Component
Figure imgf000011_0001
per 1,000 L
Bacillus sp. (about 6.00E+06 to about 1 ,00E+9 0,001 % - 30%
CFU) sanitising agent
Figure imgf000011_0003
cationic and/or non-ionic surfactants 5% - 15% water 40% - 80%
Figure imgf000011_0002
If desired, one or more additives including one or more colourants or fragrances may be added.
The diluted pH value is between 7 and 10.
Manufacturing Steps:
Step 1 : Add water into a mixing tank or vessel.
Step 2: Add each of the chemicals and Bacillus sp. and mix the product for 2 mins or until completely mixed.
Step 3: Decant into packaging for distribution, sale and use.
Directions for use:
Dilute probiotic Bacillus sanitiser product by adding to a bucket of water or spray bottle at 1 :10 parts water: probiotic Bacillus sanitiser and apply to the relevant surface with a mop, cloth or spray. Wipe down the surface or allow to dry naturally. It is also possible to dilute the probiotic Bacillus sanitiser in an alternative concentration as desired or specific to a particular application. EXAMPLE 2:
Dry probiotic Bacillus sanitiser
Figure imgf000012_0001
If desired, various additives may be included such as one or more colourants, or fragrances.
The diluted pH value is between 7 and 10.
Manufacturing Steps:
Step 1 : Add each of the dry chemicals and Bacillus sp. to a mechanical mixer in the quantities provided above.
Step 2: Turn on mixer and mix for 10 minutes or until thourghly mixed.
Step 3: Decant the finished dry probiotic Bacillus sanitiser into packaging for distribution, sale and use.
Directions for use:
• Mix 50g of dry probiotic Bacillus sanitiser into 10L of water in a container by stirring until dissolved.
• Store mixture in an air tight container for use the next day, or use the mixture within 3 hours of mixing.
• Allow minimum 30 seconds of contact with relevant surface for disinfecting or sanitising before wiping and or allow to air dry.
EXAMPLE 3:
Degreasing probiotic Bacillus sanitiser
Figure imgf000013_0001
If desired, one or more additives including colourants or fragrances may be added. The diluted pH value is between 9.5 and 10.5.
Manufacturing Steps:
Step 1 : Add the each of the dry chemicals and Bacillus sp. to a mechanical mixer in the quantities provided above.
Step 2: Turn on mixer and mix for 10 minutes or until thoroughly mixed.
Step 3: Decant the finished dry degreasing probiotic Bacillus sanitiser into packaging for distribution, sale and use.
• Mix 50g of dry probiotic Bacillus sanitiser into 10L of water in a container by stirring until dissolved.
• Store mixture in an air tight container for use the next day, or use the mixture within 3 hours of mixing.
• Allow minimum 30 seconds of contact with relevant surface for disinfecting or sanitising before wiping and allow to air dry.
EXAMPLE 4:
Efficacy of reconstituted powder formulation in water of probiotic sanitiser with Bacillus so. (between about 6.00E+06 to about 1.00E+9 CFU) and sodium dichloro iso cvnurate (SDIC) >50PPM chemical sanitiser
1. Bacterial pathgens Efficacy of reconstituted powder formulation in water of probiotic sanitiser with Bacillus sp. (between about 6,00E+06 to about 1 ,00E+9 CFU), sodium dichloro iso cynurate (SDIC) >50PPM chemical sanitiser, and 10% surfactant plus soda ash or sodium chloride as a filler was tested against four pathogenic bacterial species by an accredited laboratory. The pass requirements in terms of the accredited test is that the product must demonstrate at least a 5 decimal log reduction in bacteria when diluted with hard water or undiluted.
1.1. Methods
The probiotic sanitiser was tested against four bacterial species: Enterococcus hirae ATCC 10541 , Escherichia coli ATCC 10536, Pseudomonas aeruginosa ATCC 15442 and Staphylococcus aureus ATCC 6538 for a contact time of 5 minutes at 20 °C. An amount of 0.3 g/L bovine serum albumin as added as the interfering substance. Thereafter samples were tested at 37 °C for bacterial growth.
For the test to be valid, for each test organism:
• N is between 1.5x108 and 5.0x108 (8.17< log N < 8.70)
• No is between 1.5x107 and 5.0x107 (7.17< log N < 7.70)
• Nvo is between 30 and 160 (3.0x101 and 1.6x102)
• A, B, C are equal to or greater than 0.5xNvo
• Control of weighted mean counts: quotient is not lower than 5 and not higher than 15.
1.2. Results
Escherichia coli ATCC 10536 Test log reduction values
Figure imgf000014_0001
Pseudomonas aeruginosa ATCC 15442 Test log reduction values
Figure imgf000015_0001
Staphylococcus aureus ATCC 6538 Test log reduction values
Figure imgf000015_0002
Enterococcus hirae ATCC 10541 Test log reduction values
Figure imgf000015_0003
1.3. Conclusion
The probiotic sanitiser test product tested at either 60g / 10L or 90g / 10L complied with the pass criteria of SANS test 51276 (EN1276) standard, which requires at least a 99.999% kill (5 log reduction) in bacteria.
In addition, on culture of the probiotic sanitiser product after treatment, based on standard SANS 7932 the Bacillus strains remainng were found to survive, repopulate and continue to thrive having a Bacillus species (cfu/g) of 530,000.
2. Fungal pathogens
Efficacy of reconstituted powder formulation in water of probiotic sanitiser with Bacillus sp. (between about 6,00E+06 to about 1 ,00E+9 CFU), sodium dichloro iso cynurate (SDIC) >50PPM chemical sanitiser, and 10% surfactant plus soda ash or sodium chloride as a filler was tested against 2 pathogenic fungal strains by an accredited laboratory. The pass requirements in terms of the accredited test is that the product must demonstrate at least a 4 decimal log reduction in fungus when diluted with hard water or undiluted.
2. 1. Methods
The probiotic sanitiser was tested against two fungal strains: Candida albicans ATCC 10231 and Aspergillus brasiliensis ATCC 16404 for a contact time of 15 minutes at 20 °C. An amount of 0.3 g/L bovine serum albumin as added as the interfering substance. Thereafter samples were tested at 30 °C for bacterial growth.
For the test to be valid, for each test organism:
• N is between 1 .5x107 and 5.0x107 (7.17< log N < 7.70)
• No is between 1 .5x106 and 5.0x106 (6.17< log N < 6.70)
• Nvo is between 30 and 160 (3.0x101 and 1 .6x102)
• A, B, C are equal to or greater than 0.5xNvo
• Control of weighted mean counts: quotient is not lower than 5 and not higher than 15.
2.2. Results
Candida albicans ATCC 10231 Test log reduction values
Figure imgf000016_0001
Aspergillus brasiliensis ATCC 16404 Test log reduction values
Figure imgf000016_0002
2.3. Conclusion
The probiotic sanitiser test product tested at either 60g / 10L or 90g / 10L complied with the pass criteria of SANS test 53624:2011 (EN13624) standard, which requires at least a 99.99% kill (4 log reduction) in fungus.
In addition, on culture of the probiotic sanitiser product after treatment, based on standard SANS 7932 the Bacillus strains remainng were found to survive, repopulate and continue to thrive having a Bacillus species (cfu/g) of 530,000.
EXAMPLE 5:
Efficacy of liquid formulation probiotic sanitiser with Bacillus SD. ( between about 6,00E+06 to about 1,00E+9 CFU ) and quaternary ammonium compound
1% chemical sanitiser
1. Bacterial pathgens
Efficacy of liquid formulation in water of probiotic sanitiser with Bacillus sp. (between about 6,00E+06 to about 1,00E+9 CFU), quaternary ammonium compound 1% chemical sanitiser, and 10% surfactant was tested against three pathogenic bacterial species by an accredited laboratory. The pass requirements in terms of the accredited test is that the product must demonstrate at least a 5 decimal log reduction in bacteria when diluted with hard water or undiluted.
The probiotic sanitiser was tested against three bacterial species: Enterococcus hirae ATCC 10541, Pseudomonas aeruginosa ATCC 15442 and Staphylococcus aureus ATCC 6538 for a contact time of 5 minutes at 20 °C. An amount of 0.3 g/L bovine serum albumin as added as the interfering substance. Thereafter samples were tested at 37 °C for bacterial growth.
For the test to be valid, for each test organism:
• N is between 1.5x108 and 5.0x108 (8.17< log N < 8.70)
• No is between 1.5x107 and 5.0x107 (7.17< log N < 7.70)
• vo is between 30 and 160 (3.0x101 and 1.6x102)
• A, B, C are equal to or greater than 0.5xN o • Control of weighted mean counts: quotient is not lower than 5 and not higher than 15.
1.1. Results
Pseudomonas aeruginosa ATCC 15442 Test log reduction values
Figure imgf000018_0001
Staphylococcus aureus ATCC 6538 Test log reduction values
Figure imgf000018_0002
Enterococcus hirae ATCC 10541 Test log reduction values
Figure imgf000018_0003
1.2. Conclusion
The probiotic sanitiser test product tested at a dilution of 10% v/v or undiluted complied with the pass criteria of SANS test 53727:2011 (EN13727:2003) standard, which requires at least a 99.999% kill (5 log reduction) in bacteria.
2. Fungal pathogens
Efficacy of of liquid formulation in water of probiotic sanitiser with Bacillus sp. (between about 6,00E+06 to about 1 ,00E+9 CFU), quaternary ammonium compound 1% chemical sanitiser, and 10% surfactant plus soda ash or sodium chloride as a filler was tested against 2 pathogenic fungal strains by an accredited laboratory. The pass requirements in terms of the accredited test is that the product must demonstrate at least a 4 decimal log reduction in fungus when diluted with hard water or undiluted.
2.1. Methods
The probiotic sanitiser was tested against two fungal strains: Candida albicans ATCC 10231 and Aspergillus brasiliensis ATCC 16404 for a contact time of 15 minutes at 20 °C. An amount of 0.3 g/L bovine serum albumin as added as the interfering substance. Thereafter samples were tested at 30 °C for bacterial growth.
For the test to be valid, for each test organism:
• N is between 1.5x107 and 5.0x107 (7.17< log N < 7.70)
• No is between 1.5x106 and 5.0x106 (6.17< log N < 6.70)
• Nvo is between 30 and 160 (3.0x101 and 1.6x102)
• A, B, C are equal to or greater than 0.5xNvo
• Control of weighted mean counts: quotient is not lower than 5 and not higher than 15.
2.2. Results
Candida albicans ATCC 10231 Test log reduction values
Figure imgf000019_0001
Aspergillus brasiliensis ATCC 16404 Test log reduction values
Figure imgf000019_0002
2.3. Conclusion
The probiotic sanitiser test product tested at tested at a dilution of 10% v/v or undiluted complied with the pass criteria of standard SANS test 53624:2011 (EN13624) standard, which requires at least a 99.99% kill (4 log reduction) in fungus.

Claims

1. A probiotic Bacillus sanitiser for killing or inhibiting the growth of microorganisms on a surface, comprising or consisting of: a. as active ingredients, at least one species of Bacillus, at least one sanitising agent, and at least one surfactant; and b. optionally water, and/or additives including one or more colourants, fragrances, effervescent compounds, fillers including soda ash (sodium bicarbonate) or sodium chloride, degreasing agents, and cleaning agents, where no stabiliser is included.
2. The probiotic Bacillus sanitiser according to claim 1 , wherein the Bacillus comprises any one or more isolated GRAS (generally classified as safe) Bacillus species, including B. subtilis, B. pumilus, B. megaterium, B. licheniformis, B. coagulans, B. mojavensis, or B. amyloliquefaciens.
3. The probiotic Bacillus sanitiser according to either of claims 1 or 2, wherein the sanitising agent comprises any one or more of the following chemical sanitiser(s): chlorine, sodium dichloroisocyanurate (SDIC), chlorine dioxide, hypochlorous acid, hydrogen peroxide, sodium hypochorite, quaternary ammonium, alcohol including ethanol or isopropyl alcohol, or any derivative of the above.
4. The probiotic Bacillus sanitiser according to either of claims 1 or 2, wherein the one or more chemical sanitiser(s) is SDIC and/or quaternary ammonium.
5. The probiotic Bacillus sanitiser according to any one of claims 1 to 4, wherein the sanitising agent is a natural sanitiser comprising any one or more of essential oils or compounds including enzymes and/or flavonoids from antiseptic plants, including eucalyptus, neem, mint, rosemary, tea tree, witch- hazel, citrus peel, or lactic acid.
6. The probiotic Bacillus sanitiser according to any one of claims 1 to 5, wherein the surfactant is any one or more cationic and/or one or more non-ionic surfactant(s).
7. The probiotic Bacillus sanitiser according to claim 6, wherein the cationic surfactant is dimethyl distearyl ammonium chloride or sodium dodecylbenzene sulfonate.
8. The probiotic Bacillus sanitiser according to claim 6, wherein the non-ionic surfactant comprises a polar group that cannot be ionized in an aqueous solution, a fatty acid chain forming a hydrophobic component and a hydrophilic component containing non ionizable atoms of oxygen, nitrogen or sulphur, including any one or more of derivatives of polyoxyethylene (POE) or polyoxypropylene (POP), sugar esters and alkanolamides.
9. The probiotic Bacillus sanitiser according to any one of claims 1 to 8, wherein the pH of the probiotic sanitiser is between about 4.5 to about 9.5, or from about 5 to 9, or about 3.5 to 10.5, or about 8 to 9, or about 7 to 10, or about 9.5 to 10.5.
10. The probiotic Bacillus sanitiser according to any one of claims 1 to 9, which is formulated as a liquid or a dry (solid) form.
11. The probiotic Bacillus sanitiser according to claim 10, wherein the liquid form is formulated as a stock solution for further dilution by a user or distributor, or is formulated ready to use.
12. The probiotic Bacillus sanitiser according to claim 10, wherein the solid form is a granular or powder formulation which can be mixed with water to the desired liquid concentration by a user or distributor.
13. The probiotic Bacillus sanitiser according to claim 10 or 12, wherein the solid form further comprises a filler including soda ash (sodium carbonate) or sodium chloride.
14. The probiotic Bacillus sanitiser according to any one of claims 1 to 13, comprises degreasing components including soda ash (sodium carbonate), sodium tripolyphosphate, tetrapotassium pyrophosphate, sodium metasilicate anhydrous and sodium dodecylbenzene sulfonate.
15. The probiotic Bacillus sanitiser according to any one of claims 1 to 14 formulated as a liquid product comprising or consisting of per 1,000 L:
Bacillus sp. at between about 6,00E+05 to at least 0,0001% - 30% about 1 ,00E+11 colony forming units (CFU) depending on the CFU of the
Bacillis sp. used sanitising agent 10ppm - 1500ppm cationic and/or non-ionic surfactant(s) 5% - 15% water 40% - 80%
16. The probiotic Bacillus sanitiser according to any one of claims 1 to 14 formulated as a dry product comprising or consisting of per 1 ,000 g:
Bacillus sp. at between about 6,00E+05 to at least 0,0001% - 30% about 1 ,00E+11 colony forming units (CFU) depending on the CFU of the
Bacillis sp. used soda ash or sodium chloride (as filler) 60%-80% sanitising agent 10ppm - 1500ppm cationic and/or non-ionic surfactant(s) 5%-15%
17. The probiotic Bacillus sanitiser according to any one of claims 1 to 14 formulated as a chemical degreasing product comprising or consisting of per 1,000 g:
Bacillus sp. at between about 6,00E+05 to at least 0,0001% - 30% about 1 ,00E+11 colony forming units (CFU) depending on the CFU of the
Bacillis sp. used sanitising agent 10ppm - 1500ppm
Figure imgf000023_0001
sodium tripolyphosphate (technical grade) 10%- 100% tetra potassium pyrophosphate (technical 5%-10% grade) sodium metasilicate anhydrous 5%-10% sodium dodecylbenzene sulfonate 5%-10% surfactant sodium chloride
Figure imgf000023_0002
0,05%-30% soda ash (sodium carbonate) 30%-70%
18. A process for manufacturing a probiotic Bacillus sanitiser comprising or consisting of blending: a. as active ingredients, at least one species of Bacillus, at least one sanitising agent, and at least one surfactant; and b. optionally water, and/or additives including one or more colourants, fragrances, effervescent compounds, fillers including soda ash (sodium bicarbonate) or sodium chloride, degreasing agents, and cleaning agents, where no stabiliser is added.
19. The process according to claim 18, wherein the at least one surfactant is one or more cationic and/or non-ionic surfactant(s).
20. The process according to either claim 18 or claim 19, wherein the Bacillus comprises any one or more isolated GRAS (generally classified as safe) Bacillus species, including B. subtilis, B. pumilus, B. megaterium, B. licheniformis, B. coagulans, B. mojavensis, or B. amyloliquefaciens.
21. The process according to any one of claims 18 to 20, wherein the one or more sanitising agent(s) are any one or more chemical sanitiser(s) comprising: chlorine, sodium dichloroisocyanurate (SDIC), chlorine dioxide, hypochlorous acid, hydrogen peroxide, sodium hypochorite, quaternary ammonium, alcohol such as ethanol or isopropyl alcohol or any derivative thereof.
22. The process according to claim 21 , wherein the one or more chemical sanitiser(s) is SDIC and/or quaternary ammonium.
23. The process according to any one of claims 18 to 20, wherein the one or more sanitising agent(s) are any one or more natural sanitiser(s) comprising: essential oils or compounds including enzymes and/or flavonoids from antiseptic plants, including eucalyptus, neem, mint, rosemary, tea tree, witch- hazel, or citrus peel or lactic acid.
24. The process according to any one of claims 19 to 23, wherein the cationic surfactant is dimethyl distearyl ammonium chloride or sodium dodecylbenzene sulfonate.
25. The process according to any one of claims 19 to 23, wherein the non-ionic surfactant comprises a polar group that cannot be ionized in an aqueous solution, a fatty acid chain forming a hydrophobic component and a hydrophilic component containing non ionizable atoms of oxygen, nitrogen or sulphur, including any one or more of derivatives of polyoxyethylene (POE) or polyoxypropylene (POP), sugar esters and alkanolamides.
26. The process according to any one of claims 18 to 25, further comprising a step of adjusting the pH of the formulated probiotic Bacillus sanitiser to between about 4.5 to about 9.5, or from about 5 to 9, or about 3.5 to 10.5 or about 8 to 9, between about 7 to 10 or between about 9.5 to 10.5.
27. The process according to any one of claims 18 to 26, wherein the step of blending further comprises or consists of a step of providing the water to a mixing tank followed by addition of each of the active components and any of the optional additives as desired, and mixing until blended into a liquid formulation of the probiotic Bacillus sanitiser before packaging.
28. The process according to claim 27, wherein the active components and optional additives are in a dry form.
29. The process according to any one of claims 18 to 26, wherein the active components and optional additives are in dry form and the step of blending further comprises or consists of a step of adding the dry active components and optional additives to a mixer and mixing until blended into a dry formulation of the probiotic Bacillus sanitiser before packaging.
30. The process according to claim 29, further comprising a step of forming the dry formulation of probiotic Bacillus sanitiser into a tablet by stamping the dry formulation into a mould before packaging.
31. A method of killing or inhibition of the growth of one or more pathogenic or undesirable microorganisms on a surface by application of the probiotic Bacillus sanitiser according to any one of claims 1 to 17.
32. The method according to claim 31, wherein the microorganisms include bacteria, viruses, fungi, protozoa or algae.
33. The method according to claim 31, wherein the microorganisms are bacteria and/or fungi.
34. The method according to any one of claims 31 to 33, wherein the surface comprises any surface present in an industrial, medical, pharmaceutical, agricultural, business, public or domestic space and includes work surfaces, floors, walls, railings, handles, operating buttons, coveyers, or processing or packaging equipment.
35. The method according to any one of claims 31 to 34, wherein the method further comprises a step of dilution in water of a liquid formulation of the probiotic Bacillus sanitiser to a desired concentration prior to application.
36. The method according to any one of claims 31 to 34, further comprising a first step of dissolving a dry formulation of the probiotic Bacillus sanitiser in water to obtain a liquid formulation of a desired concentration prior to application.
37. The method according to claim 36, wherein the liquid formulation of the probiotic Bacillus sanitiser is used within 3 hours of mixing, or if stored in an air tight container, within 12 hours of mixing.
38. The method according to any one of claims 31 to 37, wherein the application comprises spraying a liquid formulation of the probiotic Bacillus sanitiser at a desired concentration onto the surface and wiping the surface, followed by allowing the surface to dry naturally.
39. The method according to any one of claims 31 to 37, wherein the application comprises providing a bucket containing a liquid formulation of the probiotic Bacillus sanitiser at the desired concentration, and application of the liquid formulation of the probiotic Bacillus sanitiser to the surface by means of a mop or cloth dipped into the bucket and then wiping or mopping the surface, followed by allowing the surface to dry naturally.
PCT/IB2021/054415 2020-05-27 2021-05-21 Probiotic bacillus sanitiser WO2021240315A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA202003127 2020-05-27
ZA2020/03127 2020-05-27

Publications (1)

Publication Number Publication Date
WO2021240315A1 true WO2021240315A1 (en) 2021-12-02

Family

ID=76502756

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2021/054415 WO2021240315A1 (en) 2020-05-27 2021-05-21 Probiotic bacillus sanitiser

Country Status (1)

Country Link
WO (1) WO2021240315A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023278306A1 (en) * 2020-03-02 2023-01-05 Air Protein, Inc. Structured high-protein meat analogue compositions

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863882A (en) * 1996-01-16 1999-01-26 Sybron Chemical Holdings, Inc. Cleaner and sanitizer formulation
WO2000063338A1 (en) * 1999-04-16 2000-10-26 Spartan Chemical Company, Inc. Aqueous disinfectant and hard surface cleaning composition and method of use
CN101475882A (en) * 2009-01-19 2009-07-08 浙江大学 Cleanser containing microorganism and preparation thereof
US20090311136A1 (en) * 2001-08-23 2009-12-17 Manning Jr James T Enzymatic antibacterial cleaner having high pH stability
EP2329893A1 (en) * 2009-12-02 2011-06-08 Metatecta, naamloze vennootschap Method for the microbiological cleaning of an interior space
US20110274673A1 (en) * 2010-05-04 2011-11-10 Novozymes Biologicals, Inc. Bacillus amyloliquefaciens Strain
CN105557689A (en) * 2015-12-19 2016-05-11 佛山市艳晖生物科技有限公司 Bacillus wettable powder containing brassinolide and preparation method thereof
US20160262376A1 (en) * 2014-07-10 2016-09-15 Seipasa S.A. Bacteriostatic Agent And Biocidal Formulations
WO2017074485A1 (en) * 2015-10-30 2017-05-04 Z Probiotics Inc. Dba Z Bioscience Inc. Probiotic compositions and uses thereof
CN107242251A (en) * 2017-06-29 2017-10-13 无锡拜奥生物技术有限公司 The degradable disinfection tablet of use in dishwasher
MX2019000310A (en) * 2019-01-08 2019-09-10 Mantenimiento Quim Industrial S A De C V Multifunctional composition based on copper oxide nanoparticles (ii).
EP3685669A1 (en) * 2019-01-23 2020-07-29 Chrisal NV Composition for the decontamination and inoculation of surfaces

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863882A (en) * 1996-01-16 1999-01-26 Sybron Chemical Holdings, Inc. Cleaner and sanitizer formulation
WO2000063338A1 (en) * 1999-04-16 2000-10-26 Spartan Chemical Company, Inc. Aqueous disinfectant and hard surface cleaning composition and method of use
US20090311136A1 (en) * 2001-08-23 2009-12-17 Manning Jr James T Enzymatic antibacterial cleaner having high pH stability
CN101475882A (en) * 2009-01-19 2009-07-08 浙江大学 Cleanser containing microorganism and preparation thereof
EP2329893A1 (en) * 2009-12-02 2011-06-08 Metatecta, naamloze vennootschap Method for the microbiological cleaning of an interior space
US20110274673A1 (en) * 2010-05-04 2011-11-10 Novozymes Biologicals, Inc. Bacillus amyloliquefaciens Strain
US20160262376A1 (en) * 2014-07-10 2016-09-15 Seipasa S.A. Bacteriostatic Agent And Biocidal Formulations
WO2017074485A1 (en) * 2015-10-30 2017-05-04 Z Probiotics Inc. Dba Z Bioscience Inc. Probiotic compositions and uses thereof
CN105557689A (en) * 2015-12-19 2016-05-11 佛山市艳晖生物科技有限公司 Bacillus wettable powder containing brassinolide and preparation method thereof
CN107242251A (en) * 2017-06-29 2017-10-13 无锡拜奥生物技术有限公司 The degradable disinfection tablet of use in dishwasher
MX2019000310A (en) * 2019-01-08 2019-09-10 Mantenimiento Quim Industrial S A De C V Multifunctional composition based on copper oxide nanoparticles (ii).
EP3685669A1 (en) * 2019-01-23 2020-07-29 Chrisal NV Composition for the decontamination and inoculation of surfaces

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023278306A1 (en) * 2020-03-02 2023-01-05 Air Protein, Inc. Structured high-protein meat analogue compositions

Similar Documents

Publication Publication Date Title
US8940792B2 (en) Antimicrobial composition and methods for using same
CN1243476C (en) Bactericide compsn.
US7658953B2 (en) Enhanced activity biocidal hydrogen peroxide composition
DK2023733T3 (en) Low foaming enhanced biocidal hydrogen peroxide composition
CN101801423A (en) Method for broad spectrum, low residue disinfection with a small droplet hydrogen peroxide-based aerosol
JP6025262B2 (en) Synergistic disinfecting composition comprising essential oil
CA2636688C (en) Enhanced activity biocidal hydrogen preoxide composition
KR101913718B1 (en) Compositions for sterilization and disinfection comprising octenidine and benzalconium chloride
US20210079319A1 (en) Ambient moisture-activated hard surface treatment powder
EP2965624A1 (en) Concentrate for a disinfectant, disinfectant and process for disinfecting a surface
CN102318625A (en) Preparation of leather composite bactericidal mould inhibitor
US20070190172A1 (en) Enhanced activity biocidal hydrogen peroxide composition
WO2021240315A1 (en) Probiotic bacillus sanitiser
US20110190228A1 (en) Sanitising compositions
EP1393629A1 (en) Aqueous disinfecting compositions based on quaternary ammonium monomers
US20140314738A1 (en) Disinfecting composition
JP2002145710A (en) Disinfectant composition
WO2023213521A1 (en) Hard surface cleaning composition
US20140170237A1 (en) Antimicrobial compositions containing mixtures of fatty and hydroxyl carboxylic acids
SK7250Y1 (en) Didinfiction composition a method of prepare thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21733185

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21733185

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 21733185

Country of ref document: EP

Kind code of ref document: A1